Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Platinum-resistant Ovarian Cancer × PHI-101 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Platinum-resistant Ovarian Cancer 1 Leukemia, Myeloid, Acute 1

Interventions

anlotinib 2 niraparib 1 afuresertib 1 Paclitaxel 1 PHI-101 1 Gemcitabine 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04678102 2023-06-26

CREATIVE

Seoul National University Hospital

Phase 1 Unknown

Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡